These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35727357)

  • 1. The neural signatures of psychoses in Alzheimer's disease: a neuroimaging genetics approach.
    Manca R; Pardiñas AF; Venneri A;
    Eur Arch Psychiatry Clin Neurosci; 2023 Feb; 273(1):253-267. PubMed ID: 35727357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases.
    Casanova R; Barnard RT; Gaussoin SA; Saldana S; Hayden KM; Manson JE; Wallace RB; Rapp SR; Resnick SM; Espeland MA; Chen JC;
    Neuroimage; 2018 Dec; 183():401-411. PubMed ID: 30130645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia.
    Lin BD; Pinzón-Espinosa J; Blouzard E; van der Horst MZ; Okhuijsen-Pfeifer C; van Eijk KR; Guloksuz S; Peyrot WJ; Luykx JJ;
    JAMA Psychiatry; 2023 Feb; 80(2):181-185. PubMed ID: 36542388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.
    Pries LK; Dal Ferro GA; van Os J; Delespaul P; Kenis G; Lin BD; Luykx JJ; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Şahin Cankurtaran E; Ulusoy Kaymak S; Mihaljevic MM; Andric Petrovic S; Mirjanic T; Bernardo M; Mezquida G; Amoretti S; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Can Saka M; ; Arango C; O'Donovan M; Tosato S; Rutten BPF; Guloksuz S
    Epidemiol Psychiatr Sci; 2020 Nov; 29():e182. PubMed ID: 33200977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia polygenic risk scores in youth mental health: preliminary associations with diagnosis, clinical stage and functioning.
    Crouse JJ; Carpenter JS; Iorfino F; Lin T; Ho N; Byrne EM; Henders AK; Wallace L; Hermens DF; Scott EM; Wray NR; Hickie IB
    BJPsych Open; 2021 Feb; 7(2):e58. PubMed ID: 33612137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers.
    Schork NJ; Elman JA;
    J Alzheimers Dis; 2023; 95(3):915-929. PubMed ID: 37661888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
    Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS;
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway-specific polygenic risk scores correlate with clinical status and Alzheimer's-related biomarkers.
    Schork NJ; Elman JA
    Res Sq; 2023 Mar; ():. PubMed ID: 36909609
    [No Abstract]   [Full Text] [Related]  

  • 11. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis of Alzheimer's disease: Neuropsychological and neuroimaging longitudinal study.
    D'Antonio F; Di Vita A; Zazzaro G; Brusà E; Trebbastoni A; Campanelli A; Ferracuti S; de Lena C; Guariglia C; Boccia M
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1689-1697. PubMed ID: 31368183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patients.
    Kirchner SK; Ozkan S; Musil R; Spellmann I; Kannayian N; Falkai P; Rossner M; Papiol S
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):425-431. PubMed ID: 30523404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease.
    Creese B; Vassos E; Bergh S; Athanasiu L; Johar I; Rongve A; Medbøen IT; Vasconcelos Da Silva M; Aakhus E; Andersen F; Bettella F; Braekhus A; Djurovic S; Paroni G; Proitsi P; Saltvedt I; Seripa D; Stordal E; Fladby T; Aarsland D; Andreassen OA; Ballard C; Selbaek G;
    Transl Psychiatry; 2019 Oct; 9(1):273. PubMed ID: 31641104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.
    Fanelli G; Benedetti F; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110170. PubMed ID: 33181205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal hippocampal and amygdala subfield volumetry in polygenic risk for Alzheimer's disease.
    Murray AN; Chandler HL; Lancaster TM
    Neurobiol Aging; 2021 Feb; 98():33-41. PubMed ID: 33227567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain anatomy of symptom stratification in schizophrenia: a voxel-based morphometry study.
    Delvecchio G; Lorandi A; Perlini C; Barillari M; Ruggeri M; Altamura AC; Bellani M; Brambilla P
    Nord J Psychiatry; 2017 Jul; 71(5):348-354. PubMed ID: 28290743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    Liu H; Lutz M; Luo S;
    J Alzheimers Dis; 2021; 84(3):1323-1335. PubMed ID: 34657885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of polygenic risk for schizophrenia, bipolar disorder, and depression with neural connectivity in adolescents and young adults: examining developmental and sex differences.
    Meyers JL; Chorlian DB; Bigdeli TB; Johnson EC; Aliev F; Agrawal A; Almasy L; Anokhin A; Edenberg HJ; Foroud T; Goate A; Kamarajan C; Kinreich S; Nurnberger J; Pandey AK; Pandey G; Plawecki MH; Salvatore JE; Zhang J; Fanous A; Porjesz B
    Transl Psychiatry; 2021 Jan; 11(1):54. PubMed ID: 33446638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.